LETROZOLE\RIBOCICLIB: 621 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
621
Total FAERS Reports
78 (12.6%)
Deaths Reported
80
Hospitalizations
621
As Primary/Secondary Suspect
7
Life-Threatening
3
Disabilities
First Report: 20140806 · Latest Report: 20250207
What Are the Most Common LETROZOLE\RIBOCICLIB Side Effects?
#1 Most Reported
Fatigue
69 reports (11.1%)
#2 Most Reported
Death
66 reports (10.6%)
#3 Most Reported
Nausea
57 reports (9.2%)
All LETROZOLE\RIBOCICLIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 69 | 11.1% | 3 | 11 |
| Death | 66 | 10.6% | 66 | 0 |
| Nausea | 57 | 9.2% | 3 | 3 |
| White blood cell count decreased | 39 | 6.3% | 2 | 6 |
| Diarrhoea | 35 | 5.6% | 0 | 6 |
| Rash | 27 | 4.4% | 1 | 0 |
| Alopecia | 25 | 4.0% | 0 | 3 |
| Neoplasm malignant | 25 | 4.0% | 1 | 3 |
| Malaise | 24 | 3.9% | 0 | 1 |
| Cough | 22 | 3.5% | 0 | 3 |
| Disease progression | 22 | 3.5% | 1 | 1 |
| Product dose omission issue | 22 | 3.5% | 0 | 5 |
| Vomiting | 22 | 3.5% | 0 | 3 |
| Headache | 21 | 3.4% | 0 | 2 |
| Drug ineffective | 20 | 3.2% | 0 | 1 |
| Pain | 20 | 3.2% | 0 | 5 |
| Dyspnoea | 19 | 3.1% | 2 | 5 |
| Dizziness | 17 | 2.7% | 1 | 3 |
| Illness | 17 | 2.7% | 0 | 3 |
| Constipation | 16 | 2.6% | 0 | 1 |
Who Reports LETROZOLE\RIBOCICLIB Side Effects? Age & Gender Data
Gender: 98.2% female, 1.8% male. Average age: 64.2 years. Most reports from: US. View detailed demographics →
Is LETROZOLE\RIBOCICLIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 15 | 0 | 3 |
| 2018 | 56 | 4 | 11 |
| 2019 | 40 | 4 | 9 |
| 2020 | 33 | 5 | 7 |
| 2021 | 9 | 4 | 2 |
| 2022 | 21 | 6 | 2 |
| 2023 | 17 | 5 | 7 |
| 2024 | 8 | 1 | 1 |
| 2025 | 1 | 0 | 0 |
What Is LETROZOLE\RIBOCICLIB Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 327 |
| Breast cancer | 114 |
| Breast cancer female | 47 |
| Breast cancer metastatic | 44 |
| Neoplasm malignant | 16 |
LETROZOLE\RIBOCICLIB vs Alternatives: Which Is Safer?
LETROZOLE\RIBOCICLIB vs LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUCOVORIN\LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUPROLIDE
LETROZOLE\RIBOCICLIB vs LEVALBUTEROL
LETROZOLE\RIBOCICLIB vs LEVAMISOLE
LETROZOLE\RIBOCICLIB vs LEVAQUIN
LETROZOLE\RIBOCICLIB vs LEVEMIR
LETROZOLE\RIBOCICLIB vs LEVETIRACETAM
LETROZOLE\RIBOCICLIB vs LEVOBUNOLOL
LETROZOLE\RIBOCICLIB vs LEVOBUPIVACAINE
Official FDA Label for LETROZOLE\RIBOCICLIB
Official prescribing information from the FDA-approved drug label.